Who founded Ora Biomedical?

Ora Biomedical was founded by Mitchell Brendon Lee, Matthew Kaeberlein in 2022.

How much funding has Ora Biomedical raised?

Ora Biomedical has disclosed $820K raised across 2 rounds.

Where is Ora Biomedical headquartered?

Ora Biomedical is headquartered in North Bend, US.

Ora Biomedical

North Bend, US · Founded 2022 · Delaware corporation

Ora Biomedical develops molecules aimed at increasing human resilience using insights from longevity medicine, targeting applications such as cancer care, skin repair, and trauma recovery. Its WormBot-AI platform combines robotics, computer vision, and deep learning to run automated high-throughput drug screening in live C. elegans models.

AI & Machine Learning Biotech Longevity

Founders & leadership

Ora Biomedical was founded in 2022 by Mitchell Brendon Lee and Matthew Kaeberlein.

Mitchell Brendon LeeCo-founder

Matthew KaeberleinCo-founder

Reported raises · per SEC filings

Form D private placements

$820K disclosed across 2 rounds · 2022–2024

▶$720KraisedJan 2024 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

John SabeyDirector
Mitchell LeeExecutive Officer, Director, Promoter
Matthew KaeberleinDirector, Promoter

Offering amount: $1M
Amount sold: $720K
First sale: Jan 2024
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100KraisedJun 2022 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Mitchell Brendon LeeExecutive Officer, Promoter
Matthew KaeberleinDirector, Promoter

Offering amount: $750K
Amount sold: $100K
First sale: Jun 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Aura Biosciences9 shared keywordsAura Biosciences develops Virus-Like Drug Conjugates (VDCs), a platform using Virus-Like Particles conjugated with drugs or loaded with nucleic acids to target solid tumors. Its lead focus is treating choroidal melanoma, a rare ocular cancer for which no first-line drug therapies currently exist.

Companies competing with Ora Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ora Biomedical do?: Ora Biomedical develops molecules aimed at increasing human resilience using insights from longevity medicine, targeting applications such as cancer care, skin repair, and trauma recovery. Its WormBot-AI platform combines robotics, computer vision, and deep learning to run automated high-throughput drug screening in live C. elegans models.
Who founded Ora Biomedical?: Ora Biomedical was founded by Mitchell Brendon Lee, Matthew Kaeberlein in 2022.
How much funding has Ora Biomedical raised?: Ora Biomedical has disclosed $820K raised across 2 rounds.
Where is Ora Biomedical headquartered?: Ora Biomedical is headquartered in North Bend, US.